By phosphorylating YB1 at Thr89 and Ser209, TOPK enhances YB1-mediated transcription of eEF1A1, triggering the AKT/mTOR signaling pathway and promoting tumor growth 61. This evidence concerns the gene AKT1 and neoplasm.